(19)
(11) EP 1 276 899 A2

(12)

(88) Date of publication A3:
14.11.2002

(43) Date of publication:
22.01.2003 Bulletin 2003/04

(21) Application number: 00986325.9

(22) Date of filing: 11.12.2000
(51) International Patent Classification (IPC)7C12Q 1/68
(86) International application number:
PCT/US0033/632
(87) International publication number:
WO 0104/2511 (14.06.2001 Gazette 2001/24)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 10.12.1999 US 170257 P
10.04.2000 US 196046 P

(71) Applicants:
  • WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
    Cambridge, MA 02142 (US)
  • Ellipsis Biotherapeutics Corporation
    Toronto,Ontario M5G 1X5 (CA)

(72) Inventors:
  • DALY, Mark
    Arlington, MA 02474 (US)
  • HUDSON, Thomas, J.
    Westmount, Quebec H2Y 2S9 (CA)
  • LANDER, Eric, S.
    Cambridge, MA 02139 (US)
  • RIOUX, John
    Cambridge, MA 02141 (US)
  • SIMINOVITCH, Kathy
    Toronto, Ontario M5H 4K3 (CA)

(74) Representative: Holdcroft, James Gerald, Dr. et al
Graham Watt & Co.St. Botolph's House7-9 St. Botolph's Road
Sevenoaks, Kent TN13 3AJ
Sevenoaks, Kent TN13 3AJ (GB)

   


(54) IBD-RELATED POLYMORPHISMS